Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian I Rini

Showing results (51-60 of 401) with videos related to

Pageof 41
Sort By:
Critical Reviews in Oncology/Hematology|July 10, 2003
The potential for prostate cancer immunotherapyBrian I Rini, Eric J Small
Urology|May 11, 2010
Editorial commentBrian I Rini, Shetal N Shah
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 10, 2004
Biology and clinical development of vascular endothelial growth factor-targeted therapy in renal cell carcinomaBrian I Rini, Eric J Small
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2007
Biological aspects and binding strategies of vascular endothelial growth factor in renal cell carcinomaBrian I Rini, W Kimryn Rathmell
JAMA Oncology|October 29, 2020
To Treat or Not to Treat-Balancing Benefits and Risks of Treatment Delay Among Patients With Cancer During the COVID-19 PandemicElizabeth Garrett-Mayer, Brian I Rini
European Urology|September 27, 2024
Refining the Tissue Source for Biomarker-based Approaches in Renal Cell CarcinomaScott M Haake, Brian I Rini
Expert Opinion on Biological Therapy|June 8, 2019
Immunotherapy for renal cell carcinomaIris Y Sheng, Brian I Rini
CA: a Cancer Journal for Clinicians|September 30, 2017
Treatment of renal cell carcinoma: Current status and future directionsPedro C Barata, Brian I Rini
The Lancet. Oncology|October 3, 2009
Resistance to targeted therapy in renal-cell carcinomaBrian I Rini, Michael B Atkins
The Journal of Urology|October 20, 2009
Editorial commentSteven C Campbell, Brian I Rini
Pageof 41

Showing results (51-60 of 401) with videos related to

Sort By:
Pageof 41
Critical Reviews in Oncology/Hematology|July 10, 2003
The potential for prostate cancer immunotherapyBrian I Rini, Eric J Small
Urology|May 11, 2010
Editorial commentBrian I Rini, Shetal N Shah
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 10, 2004
Biology and clinical development of vascular endothelial growth factor-targeted therapy in renal cell carcinomaBrian I Rini, Eric J Small
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2007
Biological aspects and binding strategies of vascular endothelial growth factor in renal cell carcinomaBrian I Rini, W Kimryn Rathmell
JAMA Oncology|October 29, 2020
To Treat or Not to Treat-Balancing Benefits and Risks of Treatment Delay Among Patients With Cancer During the COVID-19 PandemicElizabeth Garrett-Mayer, Brian I Rini
European Urology|September 27, 2024
Refining the Tissue Source for Biomarker-based Approaches in Renal Cell CarcinomaScott M Haake, Brian I Rini
Expert Opinion on Biological Therapy|June 8, 2019
Immunotherapy for renal cell carcinomaIris Y Sheng, Brian I Rini
CA: a Cancer Journal for Clinicians|September 30, 2017
Treatment of renal cell carcinoma: Current status and future directionsPedro C Barata, Brian I Rini
The Lancet. Oncology|October 3, 2009
Resistance to targeted therapy in renal-cell carcinomaBrian I Rini, Michael B Atkins
The Journal of Urology|October 20, 2009
Editorial commentSteven C Campbell, Brian I Rini
Pageof 41